Oxidative DNA Damage in Relation to the Severity of COVID-19 Infection in Duhok City, Kurdistan Region- Iraq
Published 2023-01-05
Keywords
- Oxidative DNA damage,
- lipid peroxidation,
- 8-OHdG,
- disease severity,
- prognosis
How to Cite
Copyright (c) 2023

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Abstract
Coronavirus disease 2019 (COVID-19) has rapidly spread across the globe since its outbreak in Wuhan, China, in 2019. Clinical evidence suggests higher oxidative stress in COVID-19 patients, and this worsening redox status which may contribute to disease progression. The present study aimed to investigate the oxidative Deoxyribonucleic acid damage in patients with mild and severe COVID-19 infection and to evaluate its relationship to the disease progression and severity. A case-control study was conducted from September 2021 to January 2022 in Duhok city, Kurdistan Region-Iraq. 180 individuals have participated. Among 88 COVID-19 cases, 92 healthy volunteers as the control group, with ages ranging (18-45) years. Patients were divided into two groups according to the severity of infection (mild cases, severe cases). Serum level of 8-OHdG and malondialdehyde (MDA) were assessed as oxidative stress biomarkers. Serum levels of 8-OHdG were considerably higher in patients with COVID-19 infection in comparison to the control group, (p<0.01). The further statistical analysis has revealed a significantly higher 8-OHdG in blood in female cases with severe COVID-19 infection compared cases with a mild infection, (p<0.01). Serum MDA levels in severe cases were higher, statistically significant when compared with the control group (p=0.007). Severe cases had higher level of MDA than in mild case, in male cases (p<0.05) in female cases (p<0.0001). The current data suggest that patients who were infected severely with COVID-19 are under huge oxidative stress attack. Analysis of data shows that severe cases of COVID-19 infection had significantly greater level of serum 8-OHdG than in healthy control subjects.
References
- Agrupis, K.A., Smith, C., Suzuki, S., Villanueva, A.M., Ariyoshi, K., Solante, R., Sayo, A.R. (2021). Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines. Tropical Medicine and Health, 49(1), 1-8.
- Ali, A.M., Rostam, H.M., Fatah, M.H., Noori, C.M., Ali, K.M., Tawfeeq, H.M. (2022). Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients. Immunity, Inflammation and Disease, 10(3), e582.
- Cao, L.F., Cheng, J.Y., Xu, Z., Feng, C.M., Zhao, H., Wang, X.M., Fu, L. (2022). Serum 8-hydroxydeoxyguanosine is a potential indicator for the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study. The Journal of Immunology, 208(2), 321-327.
- Delgado-Roche, L., Mesta, F. (2020). Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Archives of Medical Research, 51(5), 384-387.
- Gunson, R.N., Shouval, D., Roggendorf, M., Zaaijer, H., Nicholas, H., Holzmann, H., Group, E.C. (2003). Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. Journal of Clinical Virology, 27(3), 213-230.
- Khomich, O.A., Kochetkov, S.N., Bartosch, B., Ivanov, A.V. (2018). Redox biology of respiratory viral infections. Viruses, 10(8), 392.
- Kolgiri, V., Nagar, V., Patil, V. (2018). Association of metabolic syndrome and oxidative DNA damage in HIV/AIDS patients. Indian Journal of Clinical Biochemistry, 33(3), 273-281.
- Lovren, F., Pan, Y., Quan, A., Teoh, H., Wang, G., Shukla, P.C., Verma, S. (2008). Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. American Journal of Physiology-Heart and Circulatory Physiology, 295(4), H1377-H1384.
- Markkanen, E. (2017). Not breathing is not an option: How to deal with oxidative DNA damage. DNA Repair, 59, 82-105.
- Martin-Fernandez, M., Aller, R., Heredia-Rodriguez, M., Gomez-Sanchez, E., Martinez-Paz, P., Gonzalo-Benito, H., Tamayo-Velasco, A. (2021). Lipid peroxidation as a hallmark of severity in COVID-19 patients. Redox Biology, 48, 102181.
- Mihaljevic, O., Zivancevic-Simonovic, S., Cupurdija, V., Marinkovic, M., Vukajlovic, J.T., Markovic, A., Milosevic-Djordjevic, O. (2022). DNA damage in peripheral blood lymphocytes of severely ill COVID-19 patients in relation to inflammatory markers and parameters of hemostasis. Mutagenesis. 26, 37(3-4), 203-212
- Nasi, A., McArdle, S., Gaudernack, G., Westman, G., Melief, C., Rockberg, J., ... and Mangsbo, S. (2020). Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention. Toxicology Reports, 7, 768-771.
- Sena, C. M., Leandro, A., Azul, L., Seiça, R., Perry, G. (2018). Vascular oxidative stress: impact and therapeutic approaches. Frontiers in Physiology, 9, 1668.
- Shang, W., Dong, J., Ren, Y., Tian, M., Li, W., Hu, J., Li, Y. (2020). The value of clinical parameters in predicting the severity of COVID-19. Journal of Medical Virology, 92(10), 2188-2192.
- Suhail, S., Zajac, J., Fossum, C., Lowater, H., McCracken, C., Severson, N., Hati, S. (2020). Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review. The Protein Journal, 39(6), 644-656.
- Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Du, L. (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular and Molecular Immunology, 17(6), 613-620.
- Tantry, U.S., Bliden, K.P., Cho, A., Walia, N., Dahlen, J.R., Ens, G., Gurbel, P. A. (2021). First experience addressing the prognostic utility of novel urinary biomarkers in patients with COVID-19. In Open Forum Infectious Diseases, 8, 7, 274. US: Oxford University Press.
- Wax, R.S., and Christian, M.D. (2020). Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Canadian Journal of Anesthesia, 67(5), 568-576.
- Wlodarczyk, M., Nowicka, G. (2019). Obesity, DNA damage, and development of obesity-related diseases. International Journal Of Molecular Sciences, 20(5), 1146.
- World Health Organization. (WHO). (2020). Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020 (No. WHO/COVID-19/laboratory/2020.4). World Health Organization.
- Wu, L.L., Chiou, C.C., Chang, P.Y., Wu, J.T. (2004). Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clinica Chimica Acta, 339(1-2), 1-9.
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine. 382, 727-733.